[go: up one dir, main page]

IL124951A - Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same - Google Patents

Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same

Info

Publication number
IL124951A
IL124951A IL12495197A IL12495197A IL124951A IL 124951 A IL124951 A IL 124951A IL 12495197 A IL12495197 A IL 12495197A IL 12495197 A IL12495197 A IL 12495197A IL 124951 A IL124951 A IL 124951A
Authority
IL
Israel
Prior art keywords
microtubules
pct
taxol
depolymerisation
mitosis
Prior art date
Application number
IL12495197A
Other languages
English (en)
Other versions
IL124951A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL124951A0 publication Critical patent/IL124951A0/xx
Publication of IL124951A publication Critical patent/IL124951A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL12495197A 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same IL124951A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605024A DE19605024A1 (de) 1996-01-31 1996-01-31 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
PCT/EP1997/000440 WO1997028156A1 (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Publications (2)

Publication Number Publication Date
IL124951A0 IL124951A0 (en) 1999-01-26
IL124951A true IL124951A (en) 2003-12-10

Family

ID=7785142

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12495197A IL124951A (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same

Country Status (25)

Country Link
US (1) US6162920A (xx)
EP (1) EP0896577B1 (xx)
JP (1) JP2001505527A (xx)
KR (1) KR19990082151A (xx)
CN (1) CN1073108C (xx)
AT (1) ATE233757T1 (xx)
AU (1) AU714313B2 (xx)
BR (1) BR9708295A (xx)
CA (1) CA2244746A1 (xx)
CZ (1) CZ292504B6 (xx)
DE (2) DE19605024A1 (xx)
DK (1) DK0896577T3 (xx)
ES (1) ES2192261T3 (xx)
HU (1) HUP9901027A3 (xx)
IL (1) IL124951A (xx)
NO (1) NO983509D0 (xx)
PL (1) PL186796B1 (xx)
PT (1) PT896577E (xx)
RU (1) RU2163599C2 (xx)
SK (1) SK101198A3 (xx)
TR (1) TR199801415T2 (xx)
TW (1) TW444015B (xx)
UA (1) UA49007C2 (xx)
WO (1) WO1997028156A1 (xx)
ZA (1) ZA97847B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100851515B1 (ko) 2001-03-07 2008-08-11 다이이찌 세이야꾸 가부시기가이샤 2-아제티디논 유도체의 제조방법
DE60328486D1 (de) * 2002-05-24 2009-09-03 Angiotech Int Ag Zusammensetzungen und verfahren zur beschichtung medizinischer implantate
CN1678310A (zh) * 2002-08-24 2005-10-05 赞塔里斯有限公司 用于治疗良性和恶性肿瘤疾病的含有disorazole及其衍生物的药物
US20040220655A1 (en) 2003-03-03 2004-11-04 Sinus Rhythm Technologies, Inc. Electrical conduction block implant device
CN1296391C (zh) * 2004-03-04 2007-01-24 中国人民解放军第二军医大学 氟代羧烷基环糊精醚类化合物及其制备方法和应用
KR101223366B1 (ko) 2004-05-03 2013-01-16 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
KR20180037210A (ko) 2015-08-20 2018-04-11 입센 바이오팜 리미티드 암 치료를 위한 리포좀 이리노테칸 및 parp 저해제를 이용하는 조합요법
KR102714060B1 (ko) 2015-08-21 2024-10-08 입센 바이오팜 리미티드 리포솜 이리노테칸 및 옥살리플라틴을 포함하는 병용 치료를 이용하여 전이성 췌장암을 치료하는 방법
NZ741291A (en) 2015-10-16 2022-10-28 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
WO2018083470A1 (en) 2016-11-02 2018-05-11 Ipsen Biopharm Ltd. Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017744C1 (ru) * 1987-09-21 1994-08-15 Фудзисава Фармасьютикал Ко., Лтд. Способ получения соединений цефема или их кислотно-аддитивных солей
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
WO1994021252A1 (en) * 1993-03-22 1994-09-29 Florida State University Taxanes having a pyridyl substituted side-chain
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
DE69504843T2 (de) * 1994-06-28 1999-02-11 Pharmacia & Upjohn Co., Kalamazoo, Mich. 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen

Also Published As

Publication number Publication date
JP2001505527A (ja) 2001-04-24
UA49007C2 (uk) 2002-09-16
EP0896577A1 (en) 1999-02-17
CN1210535A (zh) 1999-03-10
BR9708295A (pt) 1999-08-03
RU2163599C2 (ru) 2001-02-27
DE69719502D1 (de) 2003-04-10
IL124951A0 (en) 1999-01-26
ATE233757T1 (de) 2003-03-15
HUP9901027A3 (en) 2001-08-28
CZ292504B6 (cs) 2003-10-15
ZA97847B (en) 1997-08-04
DE69719502T2 (de) 2004-02-19
AU1598497A (en) 1997-08-22
CN1073108C (zh) 2001-10-17
SK101198A3 (en) 1998-12-02
PT896577E (pt) 2003-06-30
WO1997028156A1 (en) 1997-08-07
PL186796B1 (pl) 2004-02-27
TR199801415T2 (xx) 1998-10-21
EP0896577B1 (en) 2003-03-05
DK0896577T3 (da) 2003-05-19
AU714313B2 (en) 1999-12-23
US6162920A (en) 2000-12-19
NO983509L (no) 1998-07-30
CA2244746A1 (en) 1997-08-07
ES2192261T3 (es) 2003-10-01
CZ242698A3 (cs) 1999-07-14
HK1018778A1 (en) 2000-01-07
PL328055A1 (en) 1999-01-04
DE19605024A1 (de) 1997-08-07
NO983509D0 (no) 1998-07-30
KR19990082151A (ko) 1999-11-15
TW444015B (en) 2001-07-01
HUP9901027A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
IL124951A (en) Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same
RU2213097C2 (ru) Гетероциклы в качестве ингибиторов адгезии лейкоцитов и vla-4-антагонистов
AU3968589A (en) Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
RU94042922A (ru) Новые соединения, способы их получения, фармацевтическая композиция
EA199900641A1 (ru) Производные арилсульфонилгидроксамовой кислоты
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
FI935821A0 (fi) Fosfonooximetylestrar av taxanderivat
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
TR199800147T1 (xx) Farnesil transferaz inhibit�rleri olarak 4-merkaptopirolidin t�revleri.
ES2168304T3 (es) Derivados del taxol.
EA200201201A1 (ru) Соединения с сульфамидной группой и содержащие эти соединения фармацевтические композиции
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
DK0579996T3 (da) 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser
EP0531419A4 (en) Bistriazenes as chemotherapeutic agents
AU8032794A (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
IL108665A (en) Pharmaceutical compositions containing ureido derivatives of substituted pyrroles, certain such novel compounds and their preparation
FI953363A0 (fi) Dimeeriblokkien synteesi ja niiden käyttö oligonukleotidien kokoamisessa
TNSN00111A1 (fr) Hydroxamides d'acides 3-(arylsulfonylamino)-tetrahydropyranne-3- carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant
von Angerer New inhibitors of tubulin polymerisation
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
PL338681A1 (en) Derivatives of 1,3-dioxolo/4,5-h/2,3-benzodiazepins as inhibitors of ampa/cainate receptors
AU7188494A (en) Use of rosmanol derivatives for producing antiradical and/or antilipoperoxidative and/or hepatotropic drugs
Roller et al. CIRCUMVENTION OF MULTIDRUG RESISTANCE BY ADDITION OF CALCIUMI CALMODULIN ANTAGONISTS TO CYTOSTATIC DRUGS

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees